A Phase I Study of BKM120 in Adult Chinese Patients With Advanced Solid Tumors
NCT01626209
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Breast Cancer, Advanced Carcinomas With Squamous Cell Histology
Interventions
DRUG:
BKM120
Sponsor
Novartis Pharmaceuticals